Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Xiidra
Treatment of moderate to severe dry eye disease in adults for whom prior artificial tears has not been sufficient
